Skip to main content

Remedium Capital Partners, LLC

Registered adviser
Location
FORT LAUDERDALE, FL
Portfolio Value
Small $451,627,233
Diversification
Moderately concentrated
Filing Date
Global Rank
#3,946 / 8,807 ▲ 704
Top Industry
Biotechnology 100.0%
3Y Alpha vs SPY
+160.8%
Period ended 4 months ago
Filed Aug 7, 2026 · 2mo
3 quarters · since Dec 2025

Regulatory profile

From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.

Holder type
Registered adviser
Form ADV roster, Oct 1, 2026
Form ADV adviser
CRD 340302
Roster of Oct 1, 2026
Regulatory AUM
$319,000,000
Main clients
Corporations (100% of AUM)

Portfolio style

Measured from the filed 13F common-share book for Jun 30, 2026, never from the firm's own description.

Style
Concentrated
The top 10 positions are 100.0% of the book (60%+)
Turnover
Turnover unknown
It needs four straight quarters of measured turnover
Horizon
Short horizon
Value-weighted holding period 3.0 quarters (under 4)

Closest benchmark: the Russell 2000 as of 2026-06-30, active share 99.4%; sector active share 90.6% against the combined 13F book's sector weights.

Over time 3 measured quarters

How the bands are measured

Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.

Clone Performance

Build a hypothetical price-return history from this filer's public 13F holdings.

View clone backtest

Portfolio Concentration

6 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026
Top Position
33.0%
+5.0 pts
Top 5
98.6%
−1.4 pts
Top 10
100.0%
0.0 pts
HHI
2,415
Dec 2025 → Jun 2026 · range 2,256 – 2,554
Moderately concentrated+159

Portfolio Trend

3 quarters · across all stocks

Sector Breakdown

As of Jun 30, 2026
Sector % Portfolio Value
Healthcare 100.0% $451,627,233

Last Quarter's Activity

Export CSV
Jun 30, 2026 vs Mar 31, 2026

Added To

Positions the filer increased
2 positions
Ticker Δ Shares Shares Value Open
— +3,100 586,691 $77,871,496

Trimmed

Positions the filer reduced
No qualifying positions this quarter.

New Positions

Positions the filer opened this quarter
1 positions
Ticker Shares Value Open

Sold Out

Positions the filer fully exited
No qualifying positions this quarter.

Portfolio Positions

Export CSV View 13F filing
6 tracked positions · $451,627,233 total · filing declares 6 positions · $451,627,235 · as of Jun 30, 2026
Ticker Company Shares Value (USD) % of Portfolio History
586,691 $77,871,496 17.24%

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.